Publication: Recombinase polymerase amplification assay for rapid diagnostics of dengue infection
Issued Date
2015-06-15
Resource Type
ISSN
19326203
Other identifier(s)
2-s2.0-84937013070
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS ONE. Vol.10, No.6 (2015)
Suggested Citation
Ahmed Abd El Wahed, Pranav Patel, Oumar Faye, Sasikanya Thaloengsok, Doris Heidenreich, Ponpan Matangkasombut, Khajohnpong Manopwisedjaroen, Anavaj Sakuntabhai, Amadou A. Sall, Frank T. Hufert, Manfred Weidmann Recombinase polymerase amplification assay for rapid diagnostics of dengue infection. PLoS ONE. Vol.10, No.6 (2015). doi:10.1371/journal.pone.0129682 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35143
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Recombinase polymerase amplification assay for rapid diagnostics of dengue infection
Abstract
© 2015 Abd El Wahed et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background: Over 2.5 billion people are exposed to the risk of contracting dengue fever (DF). Early diagnosis of DF helps to diminish its burden on public health. Real-time reverse transcription polymerase amplification assays (RT-PCR) are the standard method for molecular detection of the dengue virus (DENV). Real-time RT-PCR analysis is not suitable for on-site screening since mobile devices are large, expensive, and complex. In this study, two RT-recombinase polymerase amplification (RT-RPA) assays were developed to detect DENV1-4. Methodology/Principal Findings: Using two quantitative RNA molecular standards, the analytical sensitivity of a RT-RPA targeting the 3′non-translated region of DENV1-4 was found to range from 14 (DENV4) to 241 (DENV1-3) RNA molecules detected. The assay was specific and did not cross detect other Flaviviruses. The RT-RPA assay was tested in a mobile laboratory combining magnetic-bead based total nucleic acid extraction and a portable detection device in Kedougou (Senegal) and in Bangkok (Thailand). In Kedougou, the RT-RPA was operated at an ambient temperature of 38°C with auxiliary electricity tapped from a motor vehicle and yielded a clinical sensitivity and specificity of 98% (n=31) and 100% (n=23), respectively. While in the field trial in Bangkok, the clinical sensitivity and specificity were 72% (n=90) and 100% (n=41), respectively. Conclusions/Significance: During the first 5 days of infection, the developed DENV1-4 RT-RPA assays constitute a suitable accurate and rapid assay for DENV diagnosis. Moreover, the use of a portable fluorescence-reading device broadens its application potential to the point-of-care for outbreak investigations.